We help developing new medicines fighting new pandemic threats
26/01/24 16:02
ConsulTech is one of 13 partners from 6 countries in the recently started Horizont Europe project “APPEAL” - Antivirus Pandemic Preparedness EuropeAn pLatform, a European research initiative aimed at enhancing preparedness for future pandemics.The consortium will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
ConsulTech is supporting the implementation of APPEAL through project management, dissemination and commercialisation activities, and by contributing its experience in clinical trials. Read More…
ConsulTech is supporting the implementation of APPEAL through project management, dissemination and commercialisation activities, and by contributing its experience in clinical trials. Read More…
ConsulTech is a partner in HEU project "BeeGuards"
05/10/23 10:30
After a competitive two-stage evaluation process, the BeeGuards project was selected as one of two research projects for the “Resilient beekeeping” call funded under the Horizon Europe framework (HORIZON-CL6-2022-BIODIV-02). ConsulTech has accompanied the consortium through all phases of the application process and contract negotiations with the EU. The BeeGuards consortium, coordinated by Dr Cecilia Costa from the Italian Agricultural research Council (CREA), consists of 27 partners including scientists, beekeepers and beekeeping associations, consulting and technology companies, from 16 countries.
Read More…
Read More…
Horizon Europe: New calls for the September 2023 deadline
21/05/23 17:06
The current funding opportunities in the Horizon Europe Programme Cluster Health are listed below.
Further open funding opportunities can be found here.
Read More…
Further open funding opportunities can be found here.
Read More…
Horizon Europe: planned health calls for 2023/24
12/05/22 16:07
There is a pre-publication for project topics in cluster 1 (health) for which applications can be submitted in 2023 and 2024.
Of course, it can be assumed that there will be changes, because the discussion about the details is in full progress.
Nevertheless, the headings provide insights into the current state of affairs and indicate whether one or the other may prepare for an application.
Contact us if you are interested in the call text. Read More…
Of course, it can be assumed that there will be changes, because the discussion about the details is in full progress.
Nevertheless, the headings provide insights into the current state of affairs and indicate whether one or the other may prepare for an application.
Contact us if you are interested in the call text. Read More…
Final version of Horizon Europe programme
01/07/21 17:20
The European Commission has finally published the calls for the Horizon Europe programme. We provide you with a list of calls with other helpful information including a direct link to the call text here. Read More…
Analysing Horizon 2020 (2) - how to destruct capital and ideas
05/01/21 17:00
In the 4th call to the EIC Accelerator pilot program of the EU in October 2020, 4,223 applications from companies were submitted. The European Commission is funding 38 SMEs from 18 countries. The success rate across Europe is an incredible 0.9% !!!. In Germany 7 projects are promoted. With this absurdly low success rate, Read More…
Horizon 2020 analysis (1)
23/12/20 16:36
HORIZON 2020 has funded projects having a financial volume of € 71 billion (71,050,292,237 €) until 31.12.2020 in total. The funding of these projects had a volume of € 58.4 billion (€ 58,370,625,613). German coordinators managed Read More…
Our own research project GLIOTHER
09/09/20 13:54
Glioma therapy
ConsulTech and Charité Berlin (Department of Nuclear Medicine) - both members of the ZIM funded NetPhasol network (ZKN0732202) start the successfully applied ZIM research project GLOITHER (16KN073267) which aims at developing a new radiotherapy for glioblastoma.
Read More…
ConsulTech and Charité Berlin (Department of Nuclear Medicine) - both members of the ZIM funded NetPhasol network (ZKN0732202) start the successfully applied ZIM research project GLOITHER (16KN073267) which aims at developing a new radiotherapy for glioblastoma.
Read More…
New IMI calls in 2020
04/01/20 12:54
The European public-private partnership „Innovative Medicines Initiative“ (IMI2) has published new calls with the following topics: Read More…
SME instrument gets EIC accelerator
16/08/19 11:40
The EC updates the "SME instrument". The new funding instrument "EIC Accelerator Pilot" (formerly: SME Instrument Phase 2) will be installed in preparation for the forthcoming EU Framework Programme "Horizon Europe (2021-2027)". Read More…